Global & Public Health (all articles)
Perspective – Let’s get real. No vaccine will work as if by magic, returning us to ‘normal’
8 Sep, 2020 | 01:22h | UTCLet’s get real. No vaccine will work as if by magic, returning us to ‘normal’ – The Guardian
WHO: Emergency use approval is a “temporary solution,” countries should wait for large clinical trials to finish to roll out a COVID-19 vaccine en masse
8 Sep, 2020 | 01:21h | UTC
An ethical framework for global vaccine allocation
8 Sep, 2020 | 01:24h | UTCAn ethical framework for global vaccine allocation – Science
Commentary: Who should get the COVID-19 vaccine first? – University of Pennsylvania School of Medicine
Commentaries on Twitter
How would #COVID19 vaccines be distributed fairly across the globe once they are made available? Prominent philosophers and bioethicists outline the "Fair Priority Model", a 3-phase plan for vaccine distribution in @ScienceMagazine. https://t.co/1gdErzkRRh
— Stanford Ethics (@StanfordEthics) September 7, 2020
A new, three-phase plan for vaccine distribution for #COVID19—called the Fair Priority Model—is “the best embodiment of the ethical values of limiting harms…and recognizing equal concern for all people,” argues this #SciMagPolicyForum. Learn more: https://t.co/WKMvqKgDjl
— Science Magazine (@ScienceMagazine) September 7, 2020
Evolution of the COVID-19 vaccine development landscape
8 Sep, 2020 | 01:18h | UTCEvolution of the COVID-19 vaccine development landscape – Nature Reviews Drug Discovery
Can you catch COVID-19 from your neighbor’s toilet?
8 Sep, 2020 | 01:12h | UTCCan you catch COVID-19 from your neighbor’s toilet? – Science
Factors contributing to healthcare professional burnout during the COVID-19 pandemic: A rapid turnaround global survey
8 Sep, 2020 | 01:14h | UTC
Meta-analysis: Chloroquine and Hydroxychloroquine do not improve outcomes in COVID-19
8 Sep, 2020 | 01:08h | UTCRelated Meta-analysis: Antirheumatic Disease Therapies for the Treatment of COVID‐19: A Systematic Review and Meta‐analysis – Arthritis & Rheumatology
Systematic review: Reduction in saturated fat intake for cardiovascular disease
8 Sep, 2020 | 01:07h | UTCReduction in saturated fat intake for cardiovascular disease – Cochrane Library
Summary: Effect of cutting down on the saturated fat we eat on our risk of heart disease – Cochrane Library
We have heard your message about long covid and we will act, says WHO
6 Sep, 2020 | 21:59h | UTCWe have heard your message about long covid and we will act, says WHO – The BMJ Opinion
Commentary on Twitter
I joined an inspiring meeting with #COVID19 patient groups. My colleague @mvankerkhove contacted these great advocates who strive to increase research, rehabilitation and recognition for people suffering long-term effects of the virus. @WHO is committed to supporting their goals. https://t.co/wJpYupcLjQ
— Tedros Adhanom Ghebreyesus (@DrTedros) August 22, 2020
A living WHO guideline on drugs for Covid-19
6 Sep, 2020 | 22:04h | UTCA living WHO guideline on drugs for covid-19 – The BMJ
Commentary on Twitter
NEW #RapidRec makes a strong recommendation for systemic corticosteroids in patients with severe and critical #COVID19 and a weak or conditional recommendation against systemic corticosteroids in patients with non-severe covid-19 https://t.co/p7loBk95Vm
— The BMJ (@bmj_latest) September 5, 2020
Post-COVID syndrome severely damages children’s hearts; ‘immense inflammation’ causing cardiac blood vessel dilation
6 Sep, 2020 | 22:03h | UTCOriginal Study: Multisystem inflammatory syndrome in children: A systematic review – EClinicalMedicine
Commentary on Twitter
#COVID19 Multisystem inflammatory syndrome in children: A systematic review
An abnormal echocardiograph was observed in 314 of 581 patients (54·0%) with depressed ejection fraction (45·1%, n = 262 of 581) comprising the most common aberrancy.https://t.co/JqgETbH3DL pic.twitter.com/GqYtvGy0oP
— EPIDATUM (@epidatum) September 5, 2020
Video: Long covid: diagnosis, management, prognosis
6 Sep, 2020 | 21:58h | UTCLong covid: diagnosis, management, prognosis – The BMJ
Commentary on Twitter
#LongCovid #BMJcovid – Many patients who have relatively mild symptoms from covid-19, continue to experience these long after the usual 12 day duration.
Our panel discusses "Long covid" – it's diagnosis, management and prognosis https://t.co/hsP1TRNCt3 via @YouTube
— The BMJ (@bmj_latest) September 5, 2020
Coronavirus reinfections: Three questions scientists are asking
6 Sep, 2020 | 21:56h | UTCCoronavirus reinfections: three questions scientists are asking – Nature
Infographic. Clinical recommendations for return to play during the COVID-19 pandemic
6 Sep, 2020 | 21:54h | UTC
Commentary on Twitter
Took a while for this to be out but excited 2 see our paper made it to infographic @BJSM_BMJ Clinical recommendations for return to play during the COVID-19 pandemichttps://t.co/rS3bCeP4Qg
Huge Collective Viewpoint by @SportswiseUK @aaashafik @GrahamHolloway4 @merseysportsmed pic.twitter.com/icYjY4D1e1— Dr Dora Papadopoulou (@Dora_Sportmed) September 4, 2020
COVID-19 in healthcare workers: A living systematic review and meta-analysis of prevalence, risk factors, clinical characteristics, and outcomes
6 Sep, 2020 | 21:49h | UTC
Commentary on Twitter
The figure summarizes the main findings of our meta-analysis published yesterday at the American Journal of Epidemiology.
Health care workers suffer a significant burden
from #COVID19 https://t.co/ymI56TRbm1
@SergioA18489499 @ISPMBern @OscarH_Franco @diromiza pic.twitter.com/NCaqD0xOET— Taulant Muka (@muka_taulant) September 2, 2020
A direct comparison of enhanced saliva to nasopharyngeal swab for the detection of SARS-CoV-2 in symptomatic patients
6 Sep, 2020 | 21:51h | UTC
Phase 1–2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine
6 Sep, 2020 | 21:44h | UTC
Russian coronavirus vaccine results have been published
6 Sep, 2020 | 21:48h | UTCCommentaries: COVID-19 vaccines: early success and remaining challenges – The Lancet AND The Russian vaccine for COVID-19 – The Lancet Respiratory Medicine AND Early-phase Russian trials reveal safety and immunogenicity of two formulations of a two-part vaccine – News Medical / The Lancet AND Russian coronavirus vaccine results have been published – here’s what they reveal – The Conversation
Commentary on Twitter
NEW—Preliminary results from Russian trials find that #COVID19 vaccine candidates led to no serious adverse events and elicit antibody response https://t.co/jGUwQa8oNd
Thread (1/8) pic.twitter.com/NWBpWDvUK3
— The Lancet (@TheLancet) September 4, 2020
Attitudes toward a potential SARS-CoV-2 vaccine: A survey of U.S. adults
6 Sep, 2020 | 21:45h | UTC
Cohort study: COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumor subtype and patient demographics
6 Sep, 2020 | 21:42h | UTCCommentaries: New study describes which cancer patients are more vulnerable to COVID-19 – University of Birmingham AND COVID-19 Prevalence and Mortality in Patients With Cancer in the UK – The ASCO Post
Editorial: Are we underestimating seroprevalence of SARS-CoV-2?
4 Sep, 2020 | 02:17h | UTCAre we underestimating seroprevalence of SARS-CoV-2? – The BMJ
Commentary: Are antibody tests underestimating the spread of COVID-19? – St. George’s University of London
Editorial: Reopening schools during COVID-19
4 Sep, 2020 | 02:16h | UTCReopening schools during COVID-19 – Science
Evolution and epidemic spread of SARS-CoV-2 in Brazil
4 Sep, 2020 | 02:11h | UTCEvolution and epidemic spread of SARS-CoV-2 in Brazil – Science
[Preprint] Diarrhea and vomiting may be a key sign of Covid-19 in children
4 Sep, 2020 | 02:12h | UTCDiarrhoea and vomiting may be key sign of Covid in children – The Guardian
Original Study: Seroprevalence of SARS-CoV-2 antibodies in children – A prospective multicentre cohort study – medRxiv
Commentary on Twitter
(1/10) Important pre-print study (interpret cautiously) of 992 UK children showing 6.9% had #SARSCoV2 antibodies, suggesting they are at similar risk of infection as adults, & that young and older children are similarly susceptible. 50% were asymptomatic.https://t.co/sUgvIlnmE0 pic.twitter.com/nxeHkAODLF
— Dr Zoë Hyde (@DrZoeHyde) September 3, 2020
COVID-19 and mRNA vaccines—first large test for a new approach
4 Sep, 2020 | 02:08h | UTCCOVID-19 and mRNA Vaccines—First Large Test for a New Approach – JAMA